English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51713155    Online Users :  870
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"peng cheng yuan"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 36-71 of 71  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

Institution Date Title Author
國立成功大學 2016-07 Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus Chuang, Wan-Long;Chien, Rong-Nan;Peng, Cheng-Yuan;Chang, Ting-Tsung;Lo, Gin-Ho;Sheen, I-Shyan;Wang, Horng-Yuan;Chen, Jyh-Jou;Yang, Jenny C.;Knox, Steven J.;Gao, Bing;Garrison, Kimberly L.;Mo, Hongmei;Pang, Phillip S.;Hsu, Yu-Chun;Hu, Tsung-Hui;Chu, Chi-Jen;Kao, Jia-Horng
國立成功大學 2016-05 Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B) Chan, Henry L. Y.;Ahn, Sang Hoon;Chang, Ting-Tsung;Peng, Cheng-Yuan;Wong, David;Coffin, Carla S.;Lim, Seng Gee;Chen, Pei-Jer;Janssen, Harry L. A.;Marcellin, Patrick;Serfaty, Lawrence;Zeuzem, Stefan;Cohen, David;Critelli, Linda;Xu, Dong;Wind-Rotolo, Megan;Cooney, Elizabeth
國立臺灣大學 2016 Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis Kao, Jia-Horng; Jensen, Donald M.; Manns, Michael P.; Jacobson, Ira; Kumada, Hiromitsu; Toyota, Joji; Heo, Jeong; Yoffe, Boris; Sievert, William; Bessone, Fernando; Peng, Cheng-Yuan; Roberts, Stuart K.; Lee, Youn-Jae; Bhore, Rafia; Mendez, Patricia; Hughes, Eric; Noviello, Stephanie; 高嘉宏
國立臺灣大學 2016 A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection Kao, Jia-Horng; Chien, Rong-Nan; Chang, Ting-Tsung; Peng, Cheng-Yuan; Hu, Tsung-Hui; Lo, Gin-Ho; Wang, Horng-Yuan; Chen, Jyh-Jou; Yang, Jenny C.; Knox, Steven J.; Han, Lingling; Mo, Hongmei; Mathias, Anita; Brainard, Diana M.; Sheen, I-Shyan; Hsu, Yu-Chun; Chu, Chi-Jen; Chuang, Wan-Long; 高嘉宏
國立臺灣大學 2016 Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus Chuang, Wan-Long; Chien, Rong-Nan; Peng, Cheng-Yuan; Chang, Ting-Tsung; Lo, Gin-Ho; Sheen, I-Shyan; Wang, Horng-Yuan; Chen, Jyh-Jou; Yang, Jenny C.; Knox, Steven J.; Gao, Bing; Garrison, Kimberly L.; Mo, Hongmei; Pang, Phillip S.; Hsu, Yu-Chun; Hu, Tsung-Hui; Chu, Chi-Jen; Kao, Jia-Horng; 高嘉宏
國立臺灣大學 2016 All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study Kao, Jia-Horng; Lee, Youn-Jae; Heo, Jeong; Ahn, Sang-Hoon; Lim, Young-Suk; Peng, Cheng-Yuan; Chang, Ting-Tsung; Torbeyns, Anne; Hughes, Eric; Bhore, Rafia; Noviello, Stephanie; 高嘉宏
國立臺灣大學 2016 Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues Tseng, Kuo-Chih; Tseng, Chih-Wei; Hsieh, Tsai-Yuan; Peng, Cheng-Yuan; Lin, Chih-Lin; Su, Tung-Hung; Tseng, Tai-Chung; Lin, Hans Hsienhong; Wang, Chia-Chi; Kao, Jia-Horng; 高嘉宏
國立臺灣大學 2016 Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan Wang, Chia-Chi; Lin, Chih-Lin; Hsieh, Tsai-Yuan; Tseng, Kuo-Chih; Peng, Cheng-Yuan; Su, Tung-Hung; Yang, Sheng-Shun; Hsu, Yu-Chun; Chen, Tsung-Ming; Kao, Jia-Horng; 高嘉宏; 蘇東弘
國立臺灣大學 2016 Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Bair, Ming-Jong; Liang, Cheng-Chao; Lei, Yung-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲
國立高雄第一科技大學 2015/05/22 偏態、峰態與非對稱系統性風險對股票報酬率之影響 彭政元; Peng, Cheng-Yuan
國立成功大學 2015-09-14 Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients Yang, Chi-Chieh; Tsai, Wei-Lun; Su, Wei-Wen; Huang, Chung-Feng; Cheng, Pin-Nan; Lo, Ching-Chu; Tseng, Kuo-Chih; Mo, Lein-Ray; Wang, Chun-Hsiang; Hsu, Shih-Jer; Lai, Hsueh-Chou; Su, Chien-Wei; Liu, Chun-Jen; Peng, Cheng-Yuan; Yu, Ming-Lung
國立臺灣大學 2015 Distinct viral evolution and quasispecies dynamics between hepatitis B e antigen seroconverters and non-seroconverters in response to interferon-based therapy Yang, Hung-Chih; Lin, Su-Ru; Liu, Chun-Jen; Peng, Cheng-Yuan; Tseng, Tai-Chung; Su, Tung-Hung; Chen, Pei-Jer; Kao, Jia-Horng; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲
國立臺灣大學 2015 HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients Peng, Cheng-Yuan; Hsieh, Tsung-Cheng; Hsieh, Tsai-Yuan; Tseng, Kuo-Chih; Lin, Chih-Lin; Su, Tung-Hung; Tseng, Tai-Chung; Lin, Hans Hsienhong; Wang, Chia-Chi; Kao, Jia-Horng; 高嘉宏
國立臺灣大學 2015 Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients Yang, Chi-Chieh; Tsai, Wei-Lun; Su, Wei-Wen; Huang, Chung-Feng; Cheng, Pin-Nan; Lo, Ching-Chu; Tseng, Kuo-Chih; Mo, Lein-Ray; Wang, Chun-Hsiang; Hsu, Shih-Jer; Lai, Hsueh-Chou; Su, Chien-Wei; Liu, Chun-Jen; Peng, Cheng-Yuan; Yu, Ming-Lung; 徐士哲; 劉俊人
國立臺灣大學 2015 Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy-The final report of C-TEAM study Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Ming-Jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲
國立臺灣大學 2015 Benefits of Antiviral Treatment and Predictors of Subsequent Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients with or without Sustained Virological Response to Peg-interferon plus Ribavirin Therapy Lee, Mei-Hsuan; Lu, Sheng-Nan; Yu, Ming-Lung; Peng, Cheng-Yuan; Sheen, I-Shyan; Liu, Chen-Hua; Kao, Jia-Horng; Chuang, Wan-Long; Yang, Hwai-I; L'Italien, Gilbert; Yuan, Yong; Chen, Chien-Jen; 劉振驊; 高嘉宏
國立成功大學 2014-11-01 All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study Manns, Michael; Pol, Stanislas; Jacobson, Ira M.; Marcellin, Patrick; Gordon, Stuart C.; Peng, Cheng-Yuan; Chang, Ting-Tsung; Everson, Gregory T.; Heo, Jeong; Gerken, Guido; Yoffe, Boris; Towner, William J.; Bourliere, Marc; Metivier, Sophie; Chu, Chi-Jen; Sievert, William; Bronowicki, Jean-Pierre; Thabut, Dominique; Lee, Youn-Jae; Kao, Jia-Horng; McPhee, Fiona; Kopit, Justin; Mendez, Patricia; Linaberry, Misti; Hughes, Eric; Noviello, Stephanie
國立成功大學 2014-08-28 Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer
臺北醫學大學 2014 Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study Su, Tung-Hung;Hu, Tsung-Hui;Chen, Chi-Yi;Huang, Yi-Hsiang;Chuang, Wan-Long;Lin, Chun-Che;Wang, Chia-Chi;Su, Wei-Wen;Peng, Cheng-Yuan;Chien, Rong-Nan;Mo, Lein-Ray;Huang, Yi-Wen;Chen, Ming-Yao;Lin, Chih-Lin;Chen, Tsung-Ming;Wang, Horng-Yuan;Tseng, Kuo-Chih;Yang, Sheng-Shun;Hsu, Shih-Jer;Suk, Fat-Moon;Hu, Chi-Tan;Hsieh, Tsai-Yuan;Ming-jong, Bair;Liang, Cheng-Chao;Tseng, Tai-Chung;Chen, Chi-Ling;Kao, Jia-Horng
國立臺灣大學 2014 Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naive Taiwanese patients with chronic hepatitis B Chien, Rong-Nan; Peng, Cheng-Yuan; Kao, Jia-Horng; Hu, Tsung-Hui; Lin, Chun-Che; Hu, Chi-Tan; Chen, Chi-Yi; Hsieh, Tsai-Yuan; Lin, Han-Chieh; Chuang, Wan-Long; 高嘉宏
國立臺灣大學 2014 Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer; 胡瑞恒; 劉俊人; 陳培哲; 李伯皇; 何明志
國立臺灣大學 2014 Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Peng, Cheng-Yuan; Chien, Rong-Nan; Mo, Lein-Ray; Huang, Yi-Wen; Chen, Ming-Yao; Lin, Chih-Lin; Chen, Tsung-Ming; Wang, Horng-Yuan; Tseng, Kuo-Chih; Yang, Sheng-Shun; Hsu, Shih-Jer; Suk, Fat-Moon; Hu, Chi-Tan; Hsieh, Tsai-Yuan; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲
國立臺北護理健康大學 2013-06 Gallstones, a cholecystectomy, chronic pancreatitis, and the risk of subsequent pancreatic cancer in diabetic patients: a population- based cohort study Lai, Hsueh-Chou;Tsai, I-Ju;Chen, Pei-Chun;Muo, Chih-Hsin;Chou, Jen-Wei;Peng, Cheng-Yuan;Lai, Shih-Wei;Sung, Fung-Chang;Lyu, Shu-Yu;Donald, E.Morisky
慈濟大學 2013 Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir Wang, Chia?Chi;Tseng, Kuo?Chih;Peng, Cheng?Yuan;Hsieh, Tsai?Yuan;Lin, Chih?Lin;Su, Tung?Hung;Tseng, Tai?Chung;Hsu, Ching?Sheng;Lin, Hans Hsienhong;Kao, Jia?Horng
國立臺灣大學 2013 Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion Yang, Hung-Chih; Chen, Chi-Ling; Shen, Yueh-Chi; Peng, Cheng-Yuan; Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲
國立臺灣大學 2013 Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir Wang, Chia-Chi; Tseng, Kuo-Chih; Peng, Cheng-Yuan; Hsieh, Tsai-Yuan; Lin, Chih-Lin; Su, Tung-Hung; Tseng, Tai-Chung; Hsu, Ching-Sheng; Lin, Hans Hsienhong; Kao, Jia-Horng; 高嘉宏
國立臺灣大學 2013 Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients Yuan, Quan; Song, Liu-Wei; Liu, Chun-Jen; Li, Zhuo; Liu, Ping-Guo; Huang, Cheng-Hao; Yan, Yan; Ge, Sheng-Xiang; Wang, Ying-Bin; Peng, Cheng-Yuan; Zhang, Jun; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Pei-Jer; Xia, Ning-Shao; 陳定信; 高嘉宏; 劉俊人; 陳培哲
國立臺灣大學 2013 Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - An interim report of C-TEAM study Su, Tung-Hung; Hu, Tsung-Hui; Lin, Chun-Che; Peng, Cheng-Yuan; Chuang, Wan-Long; Chen, Chi-Yi; Wang, Chia-Chi; Chien, Rong-Nan; Huang, Yi-Hsiang; Lin, Chih-Lin; Yang, Sheng-Shun; Huang, Yi-Wen; Hsu, Shih-Jer; Wang, Horng-Yuan; Mo, Lein-Ray; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Lei, Yung-Chao; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲
國立成功大學 2012-12 Peginterferon Lambda, a New Potential Therapeutic Option for the Treatment of Chronic Hepatitis B: A Phase 2B Comparison with Peginterferon Alfa in Patients with HBeAg-Positive Disease Chan, Henry Lik-Yuen; Ahn, Sang Hoon; Chang, Ting-Tsung; Peng, Cheng-Yuan; Wong, David K.; Coffin, Carla S.; Lim, Seng Gee; Chen, Pei-Jer; Janssen, Harry L.; Marcellin, Patrick; Serfaty, Lawrence; Zeuzem, Stefan; Hu, Wenhua; Critelli, Linda; Lopez-Talavera, Juan Carlos; Cooney, Elizabeth L.
淡江大學 2012 臺灣液晶螢幕逆物流分析與其回收再製品市場區隔研究 彭成源; Peng, Cheng-Yuan
國立臺灣大學 2012 Dynamic changes of precore and basal core promoter mutations in HBeAg-positive chronic hepatitis B patients receiving interferon therapy Yang, Hung-Chih; Chen, Chi-Ling; Shen, Yueh-Chi; Peng, Cheng-Yuan; Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲
國立成功大學 2009-05 Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage Liu, Chun-Jen; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Pin-Wen; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Lee, Ching-Chih; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer
亞洲大學 2009-02 Th1 and Th2 cytokines are elevated in HCV-infected SVR( ) patients treated with interferon-alpha 萬磊;Wan, Lei;Kung, Yung-Jen;Lin, Ying-Ju;Liao, Chiu-Chu;Jim, J.C.Sheu;Tsai, Yuhsin;Lai, Hsueh-Chou;Peng, Cheng-Yuan;Tsai, Fuu-Jen
國立臺灣大學 2006 Enhanced nuclear factor-kappa B-associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics Lee, Tzong-Hsien; Tai, Dar-In; Cheng, Cha-Ju; Sun, Chi-Shu; Lin, Ching-Yih; Sheu, Ming-Jen; Lee, Wei-Ping; Peng, Cheng-Yuan; Wang, Andrew H.-J.; Tsai, Sun-Lung
亞洲大學 2005-12 新整合課程:分年、分段、分組教改之經驗及學生評論回饋分析 Chen,Walter;Shen,Wu-Chung;Hung,Jui-Sung;Peng,Cheng-Yuan;Lin,Kuo-Juei;Lin,Chouh-Jiuan;Wu,His-Chin;Chao-Tien Hsu;Cheng-Chieh Lin;Chang-Hai Tsai
臺北醫學大學 1991 維生素A之定量分析及對大白鼠體內脂質代謝的影響 彭政元; PENG, CHENG-YUAN

Showing items 36-71 of 71  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page